Acknowledgments
The researchers were not specifically funded to do this research. The GLOW study was financed through a grant from Warner Chilcott and Sanofi to the Center for Outcomes Research, University of Massachusetts, Worcester, MA.
Conflicts of interest
Stuart Silverman, Jeffrey Curtis, Kenneth Saag, Julie Flahive, Frederick Anderson, Roland Chapurlat, Christian Roux, JC Netelenbos, Johannes Pfeilschiffer, Nelson Watts, and Juliet Compston declare no conflict of interest. Jonathan Adachi declares that he is a consultant to Actavis, Amgen, Lilly, Merck, and Novartis and is doing clinical trials with Amgen, Lilly, Merck, and Novartis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Silverman, S., Curtis, J., Saag, K. et al. International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study. Osteoporos Int 26, 419–420 (2015). https://doi.org/10.1007/s00198-014-2883-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-014-2883-2